FRI0220 Sustained clinical efficacy after multiple courses of rituximab in rheumatoid arthritis patients with inadequate response to tumour necrosis factor inhibitors: 2-year data from the repeat (repeated courses in routine clinical practice) study

C. Codreanu; I. Ancuta; R. Ionescu;

doi:10.1136/annrheumdis-2013-eular.1347

FRI0220 Sustained clinical efficacy after multiple courses of rituximab in rheumatoid arthritis patients with inadequate response to tumour necrosis factor inhibitors: 2-year data from the repeat (repeated courses in routine clinical practice) study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1347 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A447.3-A448

Author(s):

C. Codreanu ◽

I. Ancuta ◽

R. Ionescu ◽

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Tumour Necrosis Factor ◽

Clinical Efficacy ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Practice Study ◽

Necrosis Factor

Download Full-text

Comparison of tocilizumab and tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective analysis of 1603 patients managed in routine clinical practice

Clinical Rheumatology ◽

10.1007/s10067-015-2879-0 ◽

2015 ◽

Vol 34 (4) ◽

pp. 673-681 ◽

Cited By ~ 21

Author(s):

Marina Backhaus ◽

Jörg Kaufmann ◽

Constanze Richter ◽

Siegfried Wassenberg ◽

Anne-Eve Roske ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Retrospective Analysis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice

Rheumatology ◽

10.1093/rheumatology/kew467 ◽

2017 ◽

pp. kew467 ◽

Cited By ~ 5

Author(s):

Kalle J. Aaltonen ◽

Suvi Ylikylä ◽

Jaana Tuulikki Joensuu ◽

Pia Isomäki ◽

Laura Pirilä ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Clinical Practice ◽

Randomized Controlled Trials ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Routine Clinical Practice ◽

Controlled Trials ◽

Randomized Controlled ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.526 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 668.6-668

Author(s):

E. Keystone ◽

S.B. Cohen ◽

P. Emery ◽

J.M. Kremer ◽

M. Dougados ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Safety Profile ◽

Tumour Necrosis ◽

Inadequate Response ◽

Sustained Efficacy ◽

Repeat Treatment ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial

The Lancet ◽

10.1016/s0140-6736(12)61424-x ◽

2013 ◽

Vol 381 (9865) ◽

pp. 451-460 ◽

Cited By ~ 393

Author(s):

Gerd R Burmester ◽

Ricardo Blanco ◽

Christina Charles-Schoeman ◽

Jürgen Wollenhaupt ◽

Cristiano Zerbini ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Inadequate Response ◽

Phase 3 ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review

Rheumatology ◽

10.1093/rheumatology/kes217 ◽

2012 ◽

Vol 51 (12) ◽

pp. 2252-2261 ◽

Cited By ~ 43

Author(s):

R. J. Moots ◽

B. Naisbett-Groet

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Biologic Agents ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors

RMD Open ◽

10.1136/rmdopen-2016-000416 ◽

2017 ◽

Vol 3 (1) ◽

pp. e000416 ◽

Cited By ~ 21

Author(s):

Vibeke Strand ◽

Matthew Reaney ◽

Chieh-I Chen ◽

Clare W J Proudfoot ◽

Sophie Guillonneau ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Patient Reported Outcomes ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Patient Reported ◽

Necrosis Factor

Download Full-text

SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1841 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A619.3-A620 ◽

Cited By ~ 1

Author(s):

M. C. Vieira ◽

G. Wallenstein ◽

J. Bradley ◽

D. Gruben ◽

T. Koncz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

Meta-Analysis of the Clinical Efficacy of the Placebo Effect from Tumour-Necrosis-Factor Inhibitors to Treat Rheumatoid Arthritis after Methotrexate Failure

Journal of Rheumatic Diseases and Treatment ◽

10.23937/2469-5726/1510032 ◽

2016 ◽

Vol 2 (1) ◽

Cited By ~ 1

Author(s):

Julie Azaïs

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Clinical Efficacy ◽

Placebo Effect ◽

Tumour Necrosis ◽

Meta Analysis ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text

FRI0183 Sustained inhibition of structural damage in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors prior to rituximab treatment: 5-year data from the reflex study:

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.2640 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 374.1-374

Author(s):

E. Keystone ◽

S.B. Cohen ◽

P. Emery ◽

J.M. Kremer ◽

M. Dougados ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Structural Damage ◽

Inadequate Response ◽

Tumour Necrosis Factor Inhibitors ◽

Sustained Inhibition ◽

Necrosis Factor

Download Full-text

02.01 Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumour necrosis factor inhibitors: A systematic review and meta-analysis

10.1136/annrheumdis-2016-211050.1 ◽

2017 ◽

Author(s):

Hussien Ahmed ◽

Abdelrahman Ibrahim Abushouk ◽

Ammar Ismail ◽

Ahmed Elmaraezy ◽

Ahmed Said Badr ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Meta Analysis ◽

Inadequate Response ◽

Safety And Efficacy ◽

Tumour Necrosis Factor Inhibitors ◽

Necrosis Factor

Download Full-text